Therapeutic opportunities within the DNA damage response.

Pearl, Laurence H; Schierz, Amanda C; Ward, Simon E; Al-Lazikani, Bissan; Pearl, Frances M G

Pearl, Laurence H; Schierz, Amanda C; Ward, Simon E; Al-Lazikani, Bissan; Pearl, Frances M G.

Afiliación

Pearl LH; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, UK.
Schierz AC; 1] Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. [2] Bluefool Innovations, 4 May Close, Sandhurst, Berkshire GU47 0UG, UK.
Ward SE; Translational Drug Discovery Group, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UK.
Al-Lazikani B; Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK.
Pearl FM; 1] Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SM2 5NG, UK. [2] Translational Drug Discovery Group, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, UK.

Nat Rev Cancer ; 15(3): 166-80, 2015 Mar.

Article en En | MEDLINE | ID: mdl-25709118

Asunto(s)

Daño del ADN/genética; Reparación del ADN/genética; Neoplasias/tratamiento farmacológico; Humanos; Neoplasias/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Daño del ADN / Reparación del ADN / Neoplasias Límite: Humans Idioma: En Revista: Nat Rev Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google